Status asthmaticus and hospital management of asthma

Immunology and Allergy Clinics of North America

Volumn 21, Issue 3, 2001, Pages 503-533

  Spagnolo, S V ^a  

^a Critical Care Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIINFECTIVE AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; HALOTHANE; HELIUM; IMMUNOGLOBULIN E ANTIBODY; IPRATROPIUM BROMIDE; ISOFLURANE; ISOPRENALINE; KETAMINE; LEVALBUTEROL; LORAZEPAM; MAGNESIUM; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; METHYLXANTHINE; MIDAZOLAM; MONTELUKAST; MUCOLYTIC AGENT; NARCOTIC AGENT; NEUROMUSCULAR BLOCKING AGENT; PROPOFOL; SALBUTAMOL; TERBUTALINE; THIOPENTAL; ZAFIRLUKAST; ZILEUTON;

ARTIFICIAL VENTILATION; ASTHMATIC STATE; BLOOD GAS ANALYSIS; CLINICAL TRIAL; ENDOTRACHEAL INTUBATION; HUMAN; LUNG FUNCTION; METERED DOSE INHALER; MORTALITY; NEUROMUSCULAR BLOCKING; PATHOGENESIS; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; THORAX RADIOGRAPHY;

EID: 0034877588     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(05)70224-1     Document Type: Article

References (226)

1. Bicarbonate buffering in acute exacerbation of chronic respiratory failure
2. Lactic acidosis in severe asthma
3. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma
4. Asthma severity: A factor analytic investigation
5. Rapid prediction of need for hospitalization in acute asthma
6. The use of helium in the treatment of asthma and obstructive lesions in the larynx and trachea
7. A new approach to the treatment of asthma
8. Prolonged sedation of critically ill patients with midazolam or propofol: Impact on weaning and costs
9. Asthma: Better outcome at a lower cost? The role of the expert in the care system
10. Sudden death in asthma
11. Cellular events in the bronchi in mild asthma and after bronchial provocation
12. Myopathy following mechanical ventilation for acute severe asthma: The role of muscle relaxants and corticosteroids
13. Fatal asthma
14. Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration
15. The association of viral and mycoplasma infections with recurrence of wheezing in the asthmatic child
16. Iatrogenic bronchospasm occurring during clinical trials of a new mucolytic agent, acetylcysteine
17. Inhaled corticosteroids and the prevention of readmission to hospital for asthma
18. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma
19. Intravenous salbutamol in the treatment of status asthmaticus in children
20. Using helium-oxygen mixtures in the emergency management of acute upper airway obstruction
21. Eosinophilic inflammation in asthma
22. Dexamethasone and oxytetracycline reverse the potentiation of neurogenic inflammation in airways of rats with Mycoplasma pulmonis infection
23. Eosinophils, T-lymphocytes, mast cells, neutrophils and macrophages in bronchial biopsies from atopic asthmatics: Comparison with atopic nonasthma and relationship to bronchial hyper-responsiveness
24. Intensive care of status asthmaticus: A 10-year experience
25. Position and diaphoresis in acute asthma
26. Eosinophilic bronchitis is an important cause of chronic cough
27. Acid-base status affects gas exchange in canine oleic acid pulmonary edema
28. Sympathetic secretory response to hypercapnic acidosis in swine
29. Treatment of acute severe asthma assisted by hypothermia
30. In vivo and in vitro studies on the use of the guinea pig as a model for virus-provoked airway hyperreactivity
31. Occupational asthma
32. rhuMAb-E25 (E25): A novel therapy for the treatment of allergic asthma (AA)
33. Infections
34. Correction of blood pH attenuates changes in hemodynamics and organ blood flow during permissive hypercapnia
35. The structure of large and small airways in nonfatal and fatal asthma
36. 2-agonist in severe acute asthma
37. Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo
38. Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: A prospective assessment
39. Modulation of airway hyperresponsiveness
40. Human respiratory syncytial virus affects nonadrenergic noncholinergic inhibition in cotton rat airways
41. Intravenous aminophylline confers no benefit in acute asthma treated with intravenous steroids and inhaled bronchodilators
42. Extracorporeal life support for status asthmaticus
43. Markers of risk of asthma death or readmission in the 12 month following a hospital admission for asthma
44. Mechanical controlled hypoventilation in status asthmaticus
45. The nature of the neuromuscular block produced by magnesium
46. Asthma
47. Bioavailability and pharmacokinetics of prednisone in humans
48. Mucosal inflammation in asthma
49. Inhaled steroid and the risk of hospitalization for asthma
50. The pathology of asthma, with special reference to changes in the bronchial mucosa
51. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema
52. Enflurane and halothane in status asthmaticus
53. Reversible T-wave abnormality in severe acute asthma: An electrocardiographic sign of severity
54. A randomized comparison of 100-mg vs 500-mg dose of methylprednisolone in the treatment of acute asthma
55. C: Prospective multicenter study of relapse following treatment for acute asthma among adults presenting to the emergency department
56. Mechanism of bronchial hyperreactivity in normal subjects after upper respiratory tract infections
57. Permissive hypercapnia
58. An index predicting relapse and need for hospitalization in patients with acute bronchial asthma
59. Zafirlukast for symptomatic mild-moderate asthma: A 13-week multicenter study
60. Outcome of pregnancy in women requiring corticosteroids for severe asthma
61. Energy requirements of the respiratory musculature in asthma
62. Asthma and bacterial sinusitis in children
63. Parainfluenza virus infection damages inhibitory M2 muscarinic receptors on pulmonary parasympathetic nerves in the guinea pig
64. Fractional analysis of sequential induced sputum samples during sputum induction: Evidence that different lung compartments are sampled at different time points
65. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma
66. Helium-oxygen mixtures in intubated patients with static asthmaticus and respiratory acidosis
67. Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma
68. Facilitation of mechanical ventilation in status asthmaticus with continuous intravenous thiopental
69. The asthma-like pharmacology and toxicology of (S)-isomers of β-agonists
70. Neuromuscular blockade in the intensive care unit
71. A double-blind, randomized clinical trial of methylprednisolone in status asthmaticus
72. Blood serum magnesium in bronchial asthma and its treatment by administration of magnesium sulfate
73. Successful treatment of persistent extreme dyspnea: Status asthmaticus-Use of theophylline ethylene diamine intravenously
74. Use of intravenous isoproterenol for status asthmaticus in children
75. Asthma: Analysis of sudden deaths and ventilatory arrests in hospital
76. The pattern of breathing in acute severe asthma
77. Adenoviral infection and childhood asthma
78. Varieties of airway narrowing in severe and fatal asthma
79. Importance of sputum differential cell counting in the diagnosis of airway diseases
80. Asthma associated with decreased hypoxic ventilatory drive: A family study
81. IL-4 and IL-5 messenger RNA and protein in bronchial biopsies from atopic and nonatopic asthma: Evidence against "intrinsic" asthma being a distinct immunopathological entity
82. Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients
83. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor
84. Increased neutrophils and cytokines, TNF-α and IL-8, in induced sputum of non-asthmatic patients with chronic dry cough
85. An inhaled steroid improves markers of airway inflammation in patients with mild asthma
86. Pathology of asthma
87. Structural changes in asthma
88. Circumstances of death from asthma
89. Isoflurane therapy for status asthmaticus in children and adults
90. The relationship between upper respiratory infections and hospital admissions for asthma: A time-trend analysis
91. Influence of viral and bacterial respiratory infections on exacerbations and symptom severity in childhood asthma
92. Status asthmaticus with acute decompensation with therapy in a 27 year-old woman
93. Asthma in women: III: Perimenstrual asthma effects of hormone therapy
94. Heliox therapy in acute severe asthma
95. The effect of heliox in acute severe asthma
96. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD
97. Theophylline toxicity
98. Nonspecificity of the bronchoconstricting effect of histamine and acetyl-β-methylcholine in patients with obstructive airways disease
99. Detection of Mycoplasma pneumoiae in the airways of adults with chronic asthma
100. Alveolar tissue inflammation in asthma
101. Mycoplasma and chlamydia cause increased airway inflammation that is responsive to clarithromycin
102. Intravenous magnesium sulfate in acute, life-threatening asthma
103. Fatal myocardial toxicity during continuous infusion of intravenous isoproterenol therapy of asthma
104. Comparison of intravenous and nebulized salbutamol in initial treatment of severe asthma
105. Muscle weakness in mechanically ventilated patients with severe asthma
106. Diagnosing occupational asthma: Use of induced sputum
107. Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: A randomized clinical trial
108. Aminophylline treatment in severe, acute asthma
109. Acute severe asthma treated by mechanical ventilation: 10 years' experience from a district general hospital
110. Asthma deaths in hospital
111. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: A randomized, controlled trial
112. Surveillance for asthma - United States, 1960-1995
113. Treatment of bronchospasm by metereddose inhaler albuterol in mechanically ventilated patients
114. Heliox improves pulsus paradoxus and peak expiratory flow in non-intubated patients with severe asthma
115. The role of respiratory muscles in the hyperinflation of bronchial asthma
116. Asthma: Pathophysiology
117. Acute bronchial asthma: Relations between clinical and physiologic manifestations
118. Intramuscular methyl-prednisolone acetate for the prevention of relapse in acute asthma
119. Intravenous magnesium sulfate in the management of acute respiratory failure complicating asthma
120. Combine ventilator and bicarbonate strategy in the management of status asthmaticus
121. Treatment of allergic asthma with monoclonal anti-IgE antibody
122. The efficacy and safety of rhuMAb-E25 (E25) in children with allergic asthma (AA)
123. Status asthmaticus: Use of acetylcysteine during bronchoscopy and lavage to remove mucus plugs
124. Use of acetylcysteine in bronchial asthma - Another look
125. Arterial blood gases in bronchial asthma
126. Chlamydia pneumoniae and exacerbations of asthma in adults
127. Respiratory arrest in near-fatal asthma
128. 2-adrenergics and steroids are provided
129. Mechanisms of airway hypersecretion and novel therapy
130. Life-threatening status asthmaticus treated with inhaled nitric oxide
131. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma
132. Respiratory viruses and exacerbations of asthma in adults
133. Asthma
134. The effectiveness of cervical block for the treatment of status asthmaticus
135. Bronchodilating effect of intravenous magnesium sulfate in acute severe bronchial asthma
136. Continuous intravenous terbutaline infusion for adult patient with status asthmaticus
137. Bacterial infection as an important triggering factor in bronchial asthma
138. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma
139. Bronchodilating effects of intravenous magnesium sulfate in bronchial asthma
140. Treatment of status asthmaticus with intravenous magnesium sulfate
141. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow inflammation
142. Nebulizer function during mechanical ventilation
143. Halothane in status asthmaticus
144. Attempting to predict hospitalization in acute asthma
145. Contrasting properties of albuterol stereoisomers
146. Eosinophil count and eosinophil cationic protein concentration of induced sputum in the diagnosis and assessment of airway inflammation in bronchial asthma
147. Management of life-threatening asthma with intravenous isoproterenol infusion
148. Viruses as precipitants of asthma symptoms: I. Epidemiology
149. Bronchial challenge in ragweed-sensitive patients
150. Mechanical ventilation in severe exacerbation of asthma
151. Induced sputum, bronchoalveolar lavage and blood from asthmatics: Inflammatory cells, lymphocyte subsets, and soluble markers compared
152. Asthma and natural colds: Inflammatory indices in induced sputum: A feasibility study
153. The seroepidemiology of Chlamydiae in Finland over the period of 1971-1987
154. Effect of nebulized ipratropium on the hospitalization rates of children with asthma
155. Are intravenous corticosteroids required in status asthmaticus?
156. A study of the clinical course and arterial blood gas tensions of patients in status asthmaticus
157. Hypermagnesemic pseudocoma
158. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma
159. Increased interleukin 1 (IL-1) messenger RNA expression in atopic allergy and asthma
160. Treatment of acute asthma: Lack of therapeutic benefit and increase of the toxicity from aminophylline given in addition too high doses of salbutamol delivered by metered dose inhaler with spacer
161. Assessment of the patient with acute asthma in the emergency department: A factor analytic study
162. Efficacy of magnesium sulfate in acute adult asthma: A meta-analysis of randomized trials
163. Ipratropium bromide in acute adult severe asthma: A meta-analysis of randomized controlled trials
164. Mechanisms of hypoxemia in patients with status asthmaticus requiring mechanical ventilation
165. Acute effect of intravenous magnesium sulfate on airway obstruction of asthmatic patients
166. Performance of an index predicting the response of patients with acute bronchial asthma to intensive emergency department treatment
167. Sulfato de magnesio en la crisis de asthma
168. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department
169. Mycoplasma pneumoniae: Acute illness, antibiotics, and subsequent pulmonary function
170. Clinical use of extracorporeal lung assist for a patient in status asthmaticus
171. Mortality in status asthmaticus: A nine-year experience in a respiratory intensive care unit
172. Acute myocardial infarction following intravenous salbutamol
173. Use of ketamine in acute severe asthma
174. Oxygenation in status asthmaticus improves during ventilation with helium-oxygen
175. The course of asthma during pregnancy, postpartum, and with successive pregnancies: A prospective analysis
176. Rapid infusion of magnesium sulfate obviates need for intubation in status asthmaticus
177. Comparison of intramuscular triamcinolone and oral prednisone in the outpatient treatment of acute asthma: A randomized controlled trial
178. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma
179. Treatment of status asthmaticus with halothane
180. Status asthmaticus: A nine-year experience
181. Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults
182. Inhaled albuterol and oral prednisone therapy in hospitalized adult asthmatics: Does aminophylline add any benefit?
183. Management of sinusitis in the asthmatic patient
184. Theophylline toxicity: Clinical features of 116 consecutive cases
185. Incidence of acute decreases in peak expiratory flow following the use of metered-dose inhalers in asthmatic patients
186. Brain pH responses to sodium bicarbonate and carbicarb during systemic acidosis
187. Myopathy in status asthmaticus: Relation to neuromuscular blockade and corticosteroid administration
188. Extracorporeal life support for status asthmaticus
189. Treatment of status asthmaticus
190. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma
191. The use of helium-oxygen mixtures in the support of patients with status asthmaticus and respiratory acidosis
192. Early prediction of need for hospitalization in children with acute asthma
193. Magnesium sulfate as an adjunct to standard therapy in severe asthma
194. Zafirlukast improves emergency department outcomes after an acute asthma episode
195. Effect of magnesium chloride on rabbit bronchial smooth muscle
196. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department
197. Nasal polyps and sinusitis
198. Virus-induced airway obstruction and parasympathetic hyperresponsiveness in adult rats
199. Acute respiratory failure in the patient with chronic airflow obstruction
200. Clinical assessment of the patient with pulmonary disease
201. Mechanical forces producing pulmonary edema in acute asthma
202. Asthma in pregnancy: A prospective study of 198 pregnancies
203. Virus-induced airway hyperresponsiveness in man
204. Aminophylline therapy does not improve outcome and increases adverse effects in children hospitalized with acute asthmatic exacerbations
205. Low-dose inhaled corticosteroids and the prevention of death from asthma
206. High-dose inhaled versus intravenous salbutamol combined with theophylline in severe acute asthma
207. Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma
208. Risk factors for near-fatal asthma: A case control study in patients hospitalized with acute asthma
209. The effects of ventilatory pattern on hyperinflation, airway pressures, and circulation in mechanical ventilation of patients with severe air-flow obstruction
210. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma
211. Distributions of ventilation-perfusion ratios in asthma
212. Measurements of continuous distributions of ventilation-perfusion ratios: Theory
213. Sudden asphyxic asthma: A distinct entity?
214. Severe bronchial asthma requiring ventilation: A review of 20 cases and advice on management
215. Effect of continuously nebulized ipratropium bromide plus albuterol on emergency department length of stay and hospital admission rates in patients with acute bronchospasm
216. Antileukotriene drugs in the management of asthma
217. Identification of the high-risk asthmatic patient. Experience with 39 patients undergoing ventilation for status asthmaticus
218. Carbon dioxide necrosis in emphysema
219. Intravenous or inhaled salbutamol in acute asthma
220. Risk factors for morbidity in mechanically ventilated patients with acute severe asthma
221. Prevalence and nature of bronchial hyperresponsiveness in subjects with chronic obstructive pulmonary disease
222. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma
223. 22-adrenetgic receptor antagonist on moderate-to severe-type asthma
224. Facilitated referral to asthma specialist reduces relapses in asthma emergency room visits
225. Theophylline-induced seizures